Norges Bank’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $212M | Buy |
+3,026,074
| New | +$157M | 0.02% | 520 |
|
|
2026
Q1 | – | Sell |
-2,702,832
| Closed | -$79.7M | – | 870 |
|
|
2025
Q4 | $79.7M | Buy |
+2,702,832
| New | +$73.4M | 0.01% | 851 |
|
|
2025
Q3 | – | Sell |
-3,439,999
| Closed | -$94.9M | – | 971 |
|
|
2025
Q2 | $94.9M | Buy |
3,439,999
+701,459
| +26% | +$18.5M | 0.01% | 724 |
|
|
2025
Q1 | $77.6M | Sell |
2,738,540
-1,201,654
| -30% | -$42.6M | 0.01% | 776 |
|
|
2024
Q4 | $164M | Buy |
3,940,194
+171,698
| +5% | +$8.21M | 0.02% | 527 |
|
|
2024
Q3 | $252M | Buy |
3,768,496
+417,703
| +12% | +$38.4M | 0.04% | 410 |
|
|
2024
Q2 | $398M | Sell |
3,350,793
-444,084
| -12% | -$56.2M | 0.06% | 289 |
|
|
2024
Q1 | $404M | Buy |
3,794,877
+300,003
| +9% | +$30.2M | 0.06% | 278 |
|
|
2023
Q4 | $348M | Buy |
3,494,874
+117,080
| +3% | +$9.85M | 0.06% | 281 |
|
|
2023
Q3 | $349M | Buy |
3,377,794
+853,940
| +34% | +$95.3M | 0.07% | 255 |
|
|
2023
Q2 | $307M | Sell |
2,523,854
-678,439
| -21% | -$90.5M | 0.06% | 287 |
|
|
2023
Q1 | $492M | Sell |
3,202,293
-295,974
| -8% | -$48.8M | 0.11% | 182 |
|
|
2022
Q4 | $628M | Buy |
3,498,267
+19,602
| +0.6% | +$3.21M | 0.15% | 140 |
|
|
2022
Q3 | $411M | Buy |
3,478,665
+109,476
| +3% | +$16.6M | 0.11% | 183 |
|
|
2022
Q2 | $481M | Buy |
3,369,189
+327,009
| +11% | +$46.7M | 0.12% | 166 |
|
|
2022
Q1 | $524M | Sell |
3,042,180
-2,269
| -0.1% | -$382K | 0.11% | 174 |
|
|
2021
Q4 | $773M | Sell |
3,044,449
-45,668
| -1% | -$13.4M | 0.16% | 118 |
|
|
2021
Q3 | $1.19B | Sell |
3,090,117
-45,480
| -1% | -$16.8M | 0.26% | 70 |
|
|
2021
Q2 | $737M | Buy |
3,135,597
+747,612
| +31% | +$134M | 0.16% | 121 |
|
|
2021
Q1 | $313M | Buy |
2,387,985
+81,935
| +4% | +$11.9M | 0.07% | 260 |
|
|
2020
Q4 | $241M | Buy |
2,306,050
+222,707
| +11% | +$22.5M | 0.06% | 305 |
|
|
2020
Q3 | $147M | Buy |
2,083,343
+201,794
| +11% | +$14.1M | 0.04% | 411 |
|
|
2020
Q2 | $121M | Sell |
1,881,549
-423,393
| -18% | -$23.2M | 0.03% | 444 |
|
|
2020
Q1 | $69M | Buy |
2,304,942
+1,748,515
| +314% | +$40.2M | 0.02% | 565 |
|
|
2019
Q4 | $10.9M | Sell |
556,427
-252,011
| -31% | -$4.47M | ﹤0.01% | 1773 |
|
|
2019
Q3 | $12.9M | Buy |
808,438
+119,507
| +17% | +$1.77M | ﹤0.01% | 1688 |
|
|
2019
Q2 | $10.1M | Sell |
688,931
-136,069
| -16% | -$2.92M | ﹤0.01% | 1796 |
|
|
2019
Q1 | $16.8M | Hold |
825,000
| – | – | 0.01% | 1596 |
|
|
2018
Q4 | $12.6M | Buy |
+825,000
| New | +$13.6M | ﹤0.01% | 1648 |
|
Other funds holding MRNA
TP
Norges Bank's MRNA Position: Q2 2026 in Review
Norges Bank opened a new position in Moderna (MRNA) in Q2 2026: 3,026,074 shares worth $212M. The stake represents 0.02% of the portfolio and ranks #520 among its holdings. This is a return to the name: Norges Bank previously reported a position in MRNA as recently as Q4 2025.
Norges Bank first reported a position in MRNA in Q4 2018 and has held it in 29 quarters since. The position peaked at $1.19B in Q3 2021. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Norges Bank held 3,026,074 shares of Moderna worth $212M as of Q2 2026.
- Moderna was a new Norges Bank position in Q2 2026.
- Moderna made up 0.02% of Norges Bank's portfolio in Q2 2026, its #520 holding.
- Norges Bank first reported a position in Moderna in Q4 2018 and has held it in 29 quarters since.
- Norges Bank's Moderna position peaked at $1.19B in Q3 2021.
- 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.